Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist for Treatment of Acute Cannabinoid Overdose from Sanofi - Associated Press https://t.co/UmndlP0hoz
— IDRO (@IDROOhio) December 26, 2018
from Twitter https://twitter.com/IDROOhio
December 26, 2018 at 07:17AM
No comments:
Post a Comment